Back

Does the presence and indication of cardiac device influence the outcome of radiofrequency pulmonary vein isolation for atrial fibrillation?

18 March 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Atrial Fibrillation - Treatment Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Philippe Purnode

Clinique Saint-Jean, Brussels (Belgium)

61 More presentations in this session

Presentation thumbnail
Professor P. Gora (Bad Oeynhausen, DE)
Abstract Slides
Presentation thumbnail
Professor K. Neven (Essen, DE)
Abstract Slides
Presentation thumbnail
Professor N. Reinsch (Essen, DE)
Abstract Slides
Presentation thumbnail
Professor N. Reinsch (Essen, DE)
Abstract Slides
Presentation thumbnail
Professor N. Reinsch (Essen, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Atrial Fibrillation - Treatment

The Event

Event poster

EHRA 2019

18 March 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Pre-ablation rhythm as a determinant of af recurrence: a multicenter prospective analysis
13 April 2026
thumbnail
Congress Presentation
Pulmonary vein isolation with a novel radiofrequency balloon catheter: real-world predictors of single shot isolation
16 April 2023
thumbnail
Congress Presentation
Cardiac resynchronization therapy in permanent atrial fibrillation
22 May 2023
thumbnail
Congress Presentation
Safety and integrity of cardiac implantable electronic devices during and after pulsed-field ablation (SAFE-PFA registry)
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources